These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8335285)

  • 1. [Effect of palonidipine hydrochloride (TC-81), a novel calcium antagonist, on the canine coronary artery].
    Okamiya Y; Kishimoto T; Aoki K; Sunakawa K; Hoshina K; Takeshita T
    Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):23-33. PubMed ID: 8335285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of palonidipine hydrochloride (TC-81), a new dihydropyridine derivative, on various myocardial ischemic models].
    Kishimoto T; Okamiya Y; Aoki K; Ota M; Hoshina K; Takeshita T
    Nihon Yakurigaku Zasshi; 1993 Aug; 102(2):85-100. PubMed ID: 8370558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of TC-81, a new dihydropyridine derivative, on K(+)-induced contraction in rat aorta.
    Okamiya Y; Kishimoto T; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Eur J Pharmacol; 1991 Nov; 205(1):49-54. PubMed ID: 1811996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in responses to TC-81 among various arteries in dogs.
    Kishimoto T; Sunakawa K; Aoki K; Okamiya Y; Takeshita T
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):923-31. PubMed ID: 1282595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
    Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
    Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spasmolytic effect of efonidipine hydrochloride in isolated canine coronary artery: comparison with the effects of nifedipine and nisoldipine.
    Jin H; Sato R; Higashino R; Fukuda Y; Kurimoto T; Tamaki H
    Biol Pharm Bull; 1997 Feb; 20(2):196-200. PubMed ID: 9057986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.
    Cao X; Nakamura Y; Wada T; Izumi-Nakaseko H; Ando K; Zhu B; Xu B; Takahara A; Saitoh M; Sugiyama A
    Heart Vessels; 2016 Dec; 31(12):2045-2052. PubMed ID: 27194426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary collateral blood flow in acute myocardial ischemia is not increased by dihydropyridine-induced coronary vasodilatation.
    Sjöquist PO; Duker G; Almgren O
    J Cardiovasc Pharmacol; 1985; 7(4):630-6. PubMed ID: 2410700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine.
    Dubé GP; Baik YH; Schwartz A
    J Cardiovasc Pharmacol; 1985; 7(2):377-89. PubMed ID: 2581094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W; Shibasaki K; Asano M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the endothelium-independent and endothelium-dependent contraction in isolated canine cerebral arteries.
    Kanda M; Shirahase H; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1996 Jul; 46(7):663-6. PubMed ID: 8842332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
    Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.